menu

Nummular Eczema Treatment Market

Schedule Call

Nummular Eczema Treatment Market

Nummular Eczema Treatment Market by Drug Class (Immunomodulators, Antibiotics, Antihistamines), Route of Administration (Topical, Oral, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Global Outlook & Forecast 2023-2031

GR - 821854 Category: Pharmaceuticals

Number of pages: 100  |  Report Format: PDF  |  Published date: June 02, 2023

Historical Years – 2021  |  Base Year – 2022  |  Forecasted Years – 2023 to 2031


Nummular Eczema Treatment Market Scope

Report Attribute

Details

CAGR

6.60%

Base Year for Estimation

2022

Forecast Period

2023 to 2031

Historical Year

2021

Segments Covered

Drug Class, Route of Administration, Distributional Channels, and Region

Regional Scope

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global to register a revenue CAGR of 6.60% from 2023 to 2031.

Nummular Eczema Treatment Market Fundamentals

Nummular eczema is distinguished by finely defined, oval, or coin-shaped erythematous, eczematous plaques. The size of the lesion typically ranges from 1 to 10cm in diameter. Lesions are often numerous and symmetrically distributed. Predilection sites are the lower limbs, followed by the higher limbs. Patches of nummular eczemas, like atopic dermatitis, are frequently infected with Staphylococcus aureus (Staph), which must be treated with skin irritation to resolve the disease. 

Nummular eczema is an idiopathic inflammatory skin disease that mostly has a chronic and relapsing course. Many factors are thought to be responsible for this condition, such as atopic dermatitis, dry skin, allergies, or seasonal variation. Nummular eczema is clinical terminology. It is important to rule out diseases with similar patterns, such as guttate psoriasis, dermatophytosis, allergic contact dermatitis, atopic dermatitis, and stasis dermatitis.

Nummular Eczema Treatment Market Dynamics: 

Numerous factors drive the global nummular eczema treatment market revenue. The primary factor driving global market revenue is the increasing number of environmental aeroallergens, such as microbes, dust, and other pollutants. Colonizing microbes, such as Staphylococcus aureus and Clostridium albicans, over the skin surface, may cause nummular eczema. Furthermore, other factors such as the use of dehydrating soaps, an increasing number of people preferring a frequent hot water bath, and low humid environments also cause nummular eczema, resulting in market revenue growth. 

Additionally, the increasing use of certain medications or a combination of these chemicals, such as antivirals, interferon, retinoids, ribavirin, isotretinoin, and gold compounds, also contribute to the market revenue share. Isotretinoin is a traditional therapy, proven successful in many patients. These have shown significant results and hence been prescribed by doctors. This results in overall market revenue growth. Also, it has been found that patients suffering from nummular dermatitis or nummular eczema usually have a history of atopic dermatitis. Therefore, patients suffering from atopic dermatitis are also expected to contribute to the rising revenue share of the global market. According to research from SAUSHEC Dermatology and Pisa University, Nummular dermatitis has a bimodal distribution and primarily affects males and females between the ages of 50 and 65.

Moreover, the increasing number of drug developments for nummular eczema and successful clinical trials of these drugs are creating a strong product pipeline, resulting in the market revenue growth of the global nummular eczema treatments. The active drug in clinical trials is Dupilumab 300 mg/2 ml and Apremilast. These drugs are expected to drive market revenue growth if approved after successful clinical trials.

However, high cost of treatments and ineffective reimbursement policies are likely to restrain the nummular eczema treatment market revenue growth. Therefore, companies must invest significant resources in clinical trials to demonstrate safety and efficacy and gain regulatory approval.

Nummular Eczema Treatment Market Ecosystem

The global nummular eczema treatment market is analyzed from four perspectives: drug class, route of administration, distributional channels, and region.

Nummular Eczema Treatment Market Segmentation by Drug Class

Based on drug class, the global nummular eczema treatment market is segmented into immunomodulators, antibiotics, and antihistamines. 

The  immunomodulators segment is the fastest-growing segment in the global nummular eczema treatment market. Corticosteroids are the most common drugs prescribed in the nummular eczema treatment as they have immunosuppressive and anti-inflammatory activities and can suppress the symptoms. The use of mid-to-high strength (class 2-5) topical corticosteroids to afflicted skin 1-2 times per day aids in reducing inflammation. Examples of corticosteroids include hydrocortisone, triamcinolone, clobetasol, and betamethasone. Another immune suppressor topical calcineurin inhibitors are medications that work by modulating the immune response and reducing inflammation. They are typically used when corticosteroids are not suitable or for long-term management. Examples include tacrolimus (Protopic) and pimecrolimus (Elidel).

The antihistamine segment is expected to rise significantly during the forecast period. This rise in revenue share is because pruritus is proven to be relieved by antihistamines, administered topically in the form of ointment or gels or orally in the form of tablets. The antibiotics segment also accounts for a sizable revenue share in the global nummular eczema treatment market. This significant share of revenue is attributed to the supportive therapies administered for an antibacterial effect and prevention of any further infections in patients. 

Nummular Eczema Treatment Market Segmentation by Routes of Administration 

Based on routes of administration, the global nummular eczema treatment market is segmented into topical, oral, and parenteral.

The topical segment accounted for the largest market revenue share in nummular eczema treatment in 2022. This large revenue share of this segment is attributed to the widespread use of topical ointment that the doctor prescribes for maintaining an antibacterial environment near the lesion. Another factor driving this segment's revenue growth is the availability of major drug classes in the form of gels and ointments. These topical medicines keep the moisture intact, maintain proper hydration, and provide an antibacterial coverage to shield the plaque. Furthermore, emollients and moisturizers are prescribed as regular and frequent moisturizers, which are essential to nummular eczema treatment. They help hydrate the skin, restore the skin barrier, and reduce dryness and itching through petroleum jelly, creams, lotions, and ointments with ingredients like ceramides or glycerin.

The parenteral route of administration accounts for the second largest revenue share in the global nummular eczema treatment market. In severe cases of nummular eczema, systemic corticosteroids may be prescribed. These medications are delivered via injection or intravenous infusion to reduce inflammation throughout the body. The fast action of medications with the administration of multiple combination therapies, such as immunomodulators with antibiotics, contributes to a large revenue share of this segment and is expected to rise significantly during the forecast period.  

Nummular Eczema Treatment Market Segmentation by Distribution Channel

Based on the distribution channel, the global nummular eczema treatment market is segmented into hospital pharmacy, online pharmacy, and retail pharmacy.

During the forecast period, hospital pharmacy will likely dominate with a high revenue share. This huge income share might be attributed to a large number of patients visiting the hospital for the necessary diagnosis and treatment, thereby purchasing the majority of the drugs from the hospitals. Furthermore, they are available in rural or low-income communities, allowing patients to receive medications in these places as well. 

The retail pharmacy segment accounted for the second-largest revenue share in 2022. The distribution of nummular eczema medications through retail pharmacies is expanding, and there are more retail pharmacies in developed countries, which creates opportunities for market revenue expansion. Affordability, convenience, and the simple availability of therapeutic pharmaceuticals at the chosen place are some key elements promoting the market's expansion. Patients also prefer to get their prescriptions from retail pharmacies owing to their accessibility. Furthermore, guidance for the dosage and administration can be provided by the pharmacists thoroughly. 

During the forecast period, the worldwide nummular eczema treatment market is expected to grow at the fastest rate. The broad accessibility, cost-effective options, and better price range are responsible for the segment's revenue expansion. Online pharmacies also work closely with online doctors and authorized local pharmacies. Online pharmacies are more reliable in distributing medications to the populace in developed nations like the U.S. Additionally, online pharmacies have increased in emerging countries, which is expected to provide a favorable atmosphere for their development during the forecast period. 

Nummular Eczema Treatment Market Segmentation by Region

The nummular eczema treatment market is segmented based on region into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America accounted for the biggest revenue share in 2022 and is expected to dominate the market globally during the forecast period. The several substantial R&D-focused laboratories, recognized research labs, substantial healthcare spending, robust regulatory environment, and sizable patient population are all attributed to the high regional revenue share. During the forecast time frame, the prevalence of skin problems is expected to boost market revenue growth. Aside from these factors, the nummular eczema treatment market is also benefiting from the existence of highly qualified personnel working in the hospitals and research labs, product manufacturers, sizable investments in R&D, and sizable healthcare expenditures.

The market for nummular eczema in Asia Pacific currently accounts for the fastest growing revenue share worldwide and is expected to grow swiftly during the coming years. The expected revenue CAGR for Asia Pacific in Nummular Eczema market is 7.1%. In the upcoming years, market revenue growth is expected as a result of expanded R&D efforts for an effective cure, a sizable population base, growing public awareness of genetic illnesses, infrastructure development, stable business strategies, and rivalry among leading businesses.

Competitive Landscape of the Nummular Eczema Treatment Market

A list of companies operating in the global nummular eczema treatment market includes:

Strategic Developments in Nummular Eczema Treatment Market:

  • In September 2022, dupilumab (Dupixent®), a monoclonal antibody that blocks the IL-4 and IL-13 pathway by targeting the IL-4-receptor, was authorized for the treatment of moderate-to-severe atopic dermatitis (AD). Using Dupilumab in nummular eczema was proven to be promising since nummular eczema and atopic dermatitis have many causes, including decreased epidermal barrier function, widespread immune-mediated inflammation, and microbial skin colonization.
  • In September 2021, Apremilast (brand name Otezla), an oral medication, was primarily approved for treating psoriasis and psoriatic arthritis. It belongs to the drug class known as phosphodiesterase-4 (PDE4) inhibitors, which help modulate the immune response and reduce inflammation. 

Frequently Asked Questions About This Report

Nummular eczema, also called nummular dermatitis or discoid eczema, is a persistent but curable illness that develops coin-shaped lesions on the skin. These patches are usually well-defined and quite irritating. They could start to exude a clear liquid or become dry and crusty.

The expected revenue CAGR of the global nummular eczema treatment market is 6.60% during the forecast period 2023-2031.

The leading companies operating in the global nummular eczema treatment market are Eli Lilly and Co, Johnson & Johnson, Meda Pharmaceuticals, Pfizer Inc., and Sanofi SA.

Based on drug class, the immunomodulator segment accounts for the fastest growing segment in terms of revenue share.

North America dominates the global eczema market with a sizable revenue share.

Table of Content

  1. INTRODUCTION
    1. Market Ecosystem
    2. Timeline Under Consideration
      1. Historical Years – 2021
      2. Base Year – 2022
      3. Forecast Years – 2023 to 2031
    3. Currency Used in the Report
  2. RESEARCH METHODOLOGY 
    1. Research Approach
    2. Data Collection Methodology
    3. Data Sources
      1. Secondary Sources
      2. Primary Sources 
    4. Market Estimation Approach
      1. Bottom Up 
      2. Top Down 
    5. Market Forecasting Model
    6. Limitations and Assumptions
  3. PREMIUM INSIGHTS
    1. Current Market Trends (COVID-19 Perspective)
    2. Key Players & Competitive Positioning (2022) 
    3. Regulatory Landscape 
    4. Reimbursement Scenario
  4. MARKET DYNAMICS
    1. Drivers
    2. Restraints/Challenges
    3. Opportunities
  5. GLOBAL NUMMULAR ECZEMA TREATMENT MARKET - ANALYSIS & FORECAST, BY DRUG CLASS
    1. Overview
    2. Immunomodulators 
    3. Antibiotics 
    4. Antihistamines 
  6. GLOBAL NUMMULAR ECZEMA TREATMENT MARKET - ANALYSIS & FORECAST, BY ROUTE OF ADMINISTRATION
    1. Overview
    2. Topical 
    3. Oral 
    4. Parenteral 
  7. GLOBAL NUMMULAR ECZEMA TREATMENT MARKET - ANALYSIS & FORECAST, BY DISTRIBUTION CHANNEL
    1. Hospital Pharmacy
    2. Retail Pharmacy
    3. Online Pharmacy
  8. GLOBAL NUMMULAR ECZEMA TREATMENT MARKET - ANALYSIS & FORECAST, BY REGION
    1. North America Nummular Eczema Treatment Market
      1. North America Nummular Eczema Treatment Market, By Drug Class
      2. North America Nummular Eczema Treatment Market, By Route of Administration
      3. North America Nummular Eczema Treatment Market, By Distribution Channel
      4. North America Nummular Eczema Treatment Market, By Country
        1. U.S.
          1. U.S. Nummular Eczema Treatment Market, By Drug Class
          2. U.S. Nummular Eczema Treatment Market, By Route of Administration
          3. U.S. Nummular Eczema Treatment Market, By Distribution Channel
        2. Canada
          1. Canada Nummular Eczema Treatment Market, By Drug Class
          2. Canada Nummular Eczema Treatment Market, By Route of Administration
          3. Canada Nummular Eczema Treatment Market, By Distribution Channel
    2. Europe Nummular Eczema Treatment Market
      1. Europe Nummular Eczema Treatment Market, By Drug Class
      2. Europe Nummular Eczema Treatment Market, By Route of Administration 
      3. Europe Nummular Eczema Treatment Market, By Distribution Channel
      4. Europe Nummular Eczema Treatment Market, By Country/Region
        1. Germany
          1. Germany Nummular Eczema Treatment Market, By Drug Class
          2. Germany Nummular Eczema Treatment Market, By Route of Administration
          3. Germany Nummular Eczema Treatment Market, By Distribution Channel
        2. U.K.
          1. U.K. Nummular Eczema Treatment Market, By Drug Class
          2. U.K. Nummular Eczema Treatment Market, By Route of Administration
          3. U.K. Nummular Eczema Treatment Market, By Distribution Channel
        3. France
          1. France Nummular Eczema Treatment Market, By Drug Class
          2. France Nummular Eczema Treatment Market, By Route of Administration
          3. France Nummular Eczema Treatment Market, By Distribution Channel
        4. Spain
          1. Spain Nummular Eczema Treatment Market, By Drug Class
          2. Spain Nummular Eczema Treatment Market, By Route of Administration
          3. Spain Nummular Eczema Treatment Market, By Distribution Channel
        5. Italy
          1. Italy Nummular Eczema Treatment Market, By Drug Class
          2. Italy Nummular Eczema Treatment Market, By Route of Administration
          3. Italy Nummular Eczema Treatment Market, By Distribution Channel
        6. Rest of Europe 
          1. Rest of Europe Nummular Eczema Treatment Market, By Drug Class
          2. Rest of Europe Nummular Eczema Treatment Market, By Route of Administration
          3. Rest of Europe Nummular Eczema Treatment Market, By Distribution Channel 
    3. Asia Pacific Nummular Eczema Treatment Market
      1. Asia Pacific Nummular Eczema Treatment Market, By Drug Class
      2. Asia Pacific Nummular Eczema Treatment Market, By Route of Administration
      3. Asia Pacific Nummular Eczema Treatment Market, By Distribution Channel
      4. Asia Pacific Nummular Eczema Treatment Market, By Country/Region
        1. China
          1. China Nummular Eczema Treatment Market, By Drug Class
          2. China Nummular Eczema Treatment Market, By Route of Administration
          3. China Nummular Eczema Treatment Market, By Distribution Channel
        2. Japan
          1. Japan Nummular Eczema Treatment Market, By Drug Class
          2. Japan Nummular Eczema Treatment Market, By Route of Administration 
          3. Japan Nummular Eczema Treatment Market, By Distribution Channel
        3. India
          1. India Nummular Eczema Treatment Market, By Drug Class
          2. India Nummular Eczema Treatment Market, By Route of Administration
          3. India Nummular Eczema Treatment Market, By Distribution Channel
        4. South Korea
          1. South Korea Nummular Eczema Treatment Market, By Drug Class
          2. South Korea Nummular Eczema Treatment Market, By Route of Administration
          3. South Korea Nummular Eczema Treatment Market, By Distribution Channel
        5. Australia
          1. Australia Nummular Eczema Treatment Market, By Drug Class
          2. Australia Nummular Eczema Treatment Market, By Route of Administration
          3. Australia Nummular Eczema Treatment Market, By Distribution Channel
        6. Rest of Asia Pacific
          1. Rest of Asia Pacific Nummular Eczema Treatment Market, By Drug Class
          2. Rest of Asia Pacific Nummular Eczema Treatment Market, By Route of Administration
          3. Rest of Asia Pacific Nummular Eczema Treatment Market, By Distribution Channel
    4. Latin America Nummular Eczema Treatment Market
      1. Latin America Nummular Eczema Treatment Market, By Drug Class
      2. Latin America Nummular Eczema Treatment Market, By Route of Administration
      3. Latin America Nummular Eczema Treatment Market, By Distribution Channel
      4. Latin America Nummular Eczema Treatment Market, By Country/Region
        1. Brazil
          1. Brazil Nummular Eczema Treatment Market, By Drug Class
          2. Brazil Nummular Eczema Treatment Market, By Route of Administration
          3. Brazil Nummular Eczema Treatment Market, By Distribution Channel
        2. Mexico
          1. Mexico Nummular Eczema Treatment Market, By Drug Class
          2. Mexico Nummular Eczema Treatment Market, By Route of Administration
          3. Mexico Nummular Eczema Treatment Market, By Distribution Channel
        3. Argentina
          1. Argentina Nummular Eczema Treatment Market, By Drug Class
          2. Argentina Nummular Eczema Treatment Market, By Route of Administration
          3. Argentina Nummular Eczema Treatment Market, By Distribution Channel
        4. Rest of Latin America
          1. Rest of Latin America Nummular Eczema Treatment Market, By Drug Class
          2. Rest of Latin America Nummular Eczema Treatment Market, By Route of Administration
          3. Rest of Latin America Nummular Eczema Treatment Market, By Distribution Channel
    5. Middle East & Africa Nummular Eczema Treatment Market
      1. Middle East & Africa Nummular Eczema Treatment Market, By Drug Class
      2. Middle East & Africa Nummular Eczema Treatment Market, By Route of Administration
      3. Middle East & Africa Nummular Eczema Treatment Market, By Distribution Channel
      4. Middle East & Africa Nummular Eczema Treatment Market, By Country/Region
        1. GCC Countries
          1. GCC Countries Nummular Eczema Treatment Market, By Drug Class
          2. GCC Countries Nummular Eczema Treatment Market, By Route of Administration
          3. GCC Countries Nummular Eczema Treatment Market, By Distribution Channel
        2. South Africa
          1. South Africa Nummular Eczema Treatment Market, By Drug Class
          2. South Africa Nummular Eczema Treatment Market, By Route of Administration
          3. South Africa Nummular Eczema Treatment Market, By Distribution Channel
        3. Rest of Middle East & Africa
          1. Rest of Middle East & Africa Nummular Eczema Treatment Market, By Drug Class
          2. Rest of Middle East & Africa Nummular Eczema Treatment Market, By Route of Administration
          3. Rest of Middle East & Africa Nummular Eczema Treatment Market, By Distribution Channel
  9. COMPANY PROFILES        
    1. Bayer AG
      1. Business Snapshot
      2. Products/Services Offered 
      3. Financial Details* 
      4. Strategic Developments 
    2. AbbVie Inc.
    3. Eli Lilly and Co
    4. Johnson & Johnson
    5. Meda Pharmaceuticals
    6. Pfizer Inc.
    7. Sanofi SA

*Insights on financial performance are subject to the availability of information in the public domain

List of Tables

  1. Global Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million)
  2. Global Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  3. Global Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  4. Global Nummular Eczema Treatment Market, By region, 2021-2031 (US$ Million) 
  5. North America Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  6. North America Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  7. North America Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  8. North America Nummular Eczema Treatment Market, By Country, 2021-2031 (US$ Million) 
  9. U.S. Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  10. U.S. Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  11. U.S. Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  12. Canada Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  13. Canada Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  14. Canada Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  15. Europe Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  16. Europe Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  17. Europe Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  18. Europe Nummular Eczema Treatment Market, By Country/Region, 2021-2031 (US$ Million) 
  19. Germany Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  20. Germany Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  21. Germany Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million)
  22. U.K. Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  23. U.K. Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  24. U.K. Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million)
  25. France Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  26. France Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  27. France Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  28. Italy Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  29. Italy Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  30. Italy Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  31. Spain Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  32. Spain Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  33. Spain Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  34. Rest of Europe Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  35. Rest of Europe Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  36. Rest of Europe Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  37. Asia Pacific Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  38. Asia Pacific Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  39. Asia Pacific Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  40. Asia Pacific Nummular Eczema Treatment Market, By Country/Region, 2021-2031 (US$ Million) 
  41. China Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  42. China Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  43. China Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  44. Japan Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  45. Japan Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  46. Japan Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  47. India Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  48. India Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  49. India Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  50. South Korea Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  51. South Korea Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  52. South Korea Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  53. Australia Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  54. Australia Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  55. Australia Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  56. Rest of Asia Pacific Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  57. Rest of Asia Pacific Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  58. Rest of Asia Pacific Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million)
  59. Latin America Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  60. Latin America Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  61. Latin America Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  62. Latin America Nummular Eczema Treatment Market, By Country/Region, 2021–2031 (US$ Million)
  63. Brazil Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  64. Brazil Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  65. Brazil Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  66. Mexico Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  67. Mexico Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  68. Mexico Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  69. Argentina Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  70. Argentina Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  71. Argentina Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  72. Rest of Latin America Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  73. Rest of Latin America Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  74. Rest of Latin America Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million)
  75. Middle East and Africa Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  76. Middle East and Africa Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  77. Middle East and Africa Nummular Eczema Treatment Market, By Distribution Channel 2021–2031 (US$ Million)
  78. Middle East and Africa Nummular Eczema Treatment Market, By Country/Region, 2021–2031 (US$ Million)
  79. GCC Countries Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  80. GCC Countries Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  81. GCC Countries Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  82. South Africa Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  83. South Africa Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  84. South Africa Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million) 
  85. Rest of Middle East & Africa Nummular Eczema Treatment Market, By Drug Class, 2021-2031 (US$ Million) 
  86. Rest of Middle East & Africa Nummular Eczema Treatment Market, By Route of Administration, 2021–2031 (US$ Million) 
  87. Rest of Middle East & Africa Nummular Eczema Treatment Market, By Distribution Channel, 2021–2031 (US$ Million)

List of Figures

  1. Nummular Eczema Treatment Market Ecosystem  
  2. Snapshot of Global Nummular Eczema Treatment Market, 2021 & 2031 
  3. Snapshot of Global Nummular Eczema Treatment Market, By Region, 2021 & 2031 
  4. Global Nummular Eczema Treatment Market: COVID-19 Pandemic Impact Assessment 
  5. Global Nummular Eczema Treatment Market: Key Players & Competitive Positioning (2022) 
  6. ABCA4 Retinopathy Therapeutics: Market Dynamics 
  7. Global Immunomodulators Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  8. Global Antibiotics Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  9. Global Antihistamines Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  10. Global Topical Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  11. Global Oral Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  12. Global Parenteral Nummular Eczema Treatment Market 2021-2031 (US$ Million) 
  13. Global Nummular Eczema Treatment Market for Others, 2021-2031 (US$ Million) 
  14. North America Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  15. U.S. Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  16. Canada Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  17. Europe Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  18. Germany Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  19. U.K. Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  20. France Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  21. Italy Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  22. Spain Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  23. Rest of Europe Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  24. Asia Pacific Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  25. China Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  26. Japan Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  27. India Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  28. South Korea Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  29. Australia Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  30. Rest of Asia Pacific Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  31. Latin America Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  32. Brazil Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  33. Mexico Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  34. Argentina Nummular Eczema Treatment Market, 2021-2031 (US$ Million)
  35. Rest of Latin America Nummular Eczema Treatment Market, 2021-2031 (US$ Million)
  36. Middle East & Africa Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  37. GCC Countries Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  38. South Africa Nummular Eczema Treatment Market, 2021-2031 (US$ Million) 
  39. Rest of Middle East & Africa Nummular Eczema Treatment Market, 2021-2031 (US$ Million)
  40. Bayer AG Revenue from 2019 Onwards (US$ Million)
  41. AbbVie Inc. revenue from 2019 Onwards (US$ Million)
  42. Eli Lilly and Co Revenue from 2019 Onwards (US$ Million)
  43. Johnson & Johnson Revenue from 2019 Onwards (US$ Million)
  44. Meda Pharmaceuticals Revenue from 2019 Onwards (US$ Million)
  45. Pfizer Inc. Revenue from 2019 Onwards (US$ Million)
  46. Sanofi SA Revenue from 2019 Onwards (US$ Million)

Single User License
Single User License
Multi User License
Enterprise User License
$4,750.00
Provides access to one user only and should not be shared with other employees within the organization.
Provides access to up to five users within the department or an organization.
Provides access to all the employees in the organization. The report can also be shared with subsidiaries, sister concerns and group entities.
Grants user/users’ access to quantitative data only, which includes but is not restricted to numeric data, tables, and charts as defined by Growth+ Reports.
  • What are the significant driving and restraining factors for the Nummular Eczema Treatment Market?
  • Who are the leading companies in the market?
  • Where can you find the updates on recent developments by market players?
  • When is the right time to get discounts on complete market reports?
  • Why to invest in the Nummular Eczema Treatment Market?
  • How to improve your organizational performance?
  • How to shift customers towards your brand?

Recommended Reports